Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerPolicy UpdatesPsychiatry/Behavioral HealthAmbetter Nevada Biofeedback Coverage Prior Auth | …
    Ask Trek AI about this page
    CurrentAmbetter NevadaPolicy CP.BH.300

    Biofeedback for Behavioral Health Disorders

    Customize your policy alerts

    Sign up for Ambetter Nevada Policy CP.BH.300 alerts

    Get alerted when Policy CP.BH.300 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity criteria, limits, and clinical guidance for outpatient biofeedback/neurofeedback as an adjunctive treatment for certain behavioral health diagnoses for members/enrollees of Centene Advanced Behavioral Health and affiliated health plans.

    Policy Summary
    PayerAmbetter Nevada
    PolicyBiofeedback for Behavioral Health Disorders
    Policy CodePolicy CP.BH.300
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization to request up to 25 initial biofeedback sessions and document diagnosis, validated severity scores, treatment plan and practitioner training for review.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    up to 25

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    initial sessions
    up to 20continuation sessions
    25%required improvement for continuation
    50%discharge threshold
    anxiety, PTSDcovered indications

    Coverage Criteria for Biofeedback / Neurofeedback

    Initial Therapy

    Covered when ALL of the following are met

    Initial behavioral health biofeedback (up to 25 sessions): A. Diagnosis of anxiety disorder or post-traumatic stress disorder as listed in the most current DSM; B. Significant symptoms interfering with functioning in at least one life area as measured by a widely recognized validated standardized severity scale focused on the symptom profile; C. Member/enrollee is motivated to actively participate in the treatment plan, including practice and follow-through at home; D. Member/enrollee can participate in the treatment plan (physically and intellectually); E. Comprehensive treatment plan includes biofeedback as an adjunctive intervention in addition to other primary evidence-based interventions; F. The condition can be appropriately treated with biofeedback (existing pathology does not prevent success); G. Evidence that standard evidence-based outpatient treatments (including psychotherapy and medication management) are insufficient to treat the condition safely and effectively; H. There is a readily identifiable response measurable by a symptom-specific validated standardized scale; I. Biofeedback training is performed by a physician or qualified non-physician practitioner who has undergone biofeedback training and certification (may include nurse practitioners, physician assistants, qualified mental health professionals, psychologists, and where applicable, biofeedback technicians); J. Individualized treatment plan with clearly stated realistic goals and objectives; K. Treatment is structured to achieve optimum documented benefit; L. There is a documented planned transition out of biofeedback from the start of treatment, which may include ensuring the ability to continue learned techniques independently after sessions end.up to 25 sessions

    All elements A through L must be documented

    Continuation Therapy

    Additional continuation sessions (up to 20) reviewed case-by-case by Medical Director when ALL of the following are met

    Continuation (up to an additional 20 sessions): A. Initial criteria continue to be met; B. Session frequency is scheduled at a rate consistent with presenting symptoms and showing results (a lower rate may impede progress); C. Progress related to biofeedback can be clearly described by at least a 25% reduction in severity compared to the last review; D. When medically necessary, appropriate psychopharmacological intervention is provided; E. There is a documented planned transition out of biofeedback from the start of treatment which includes: E.1 a plan ensuring the member can continue biofeedback-learned techniques independently after sessions end; and E.2 a goal with a clear and reasonable score range on a validated scale demonstrating meaningful progress.up to 20 additional sessions

    Medical Director review required

    Discharge / No longer medically necessary

    Discharge or biofeedback deemed no longer medically necessary when ANY one of the following is met

    Discontinuation criteria: A. Documented goals and objectives have been substantially achieved; B. Member/enrollee no longer meets initiation or continuation criteria, or symptom severity has dropped by 50%; C. Member/enrollee is not engaging in treatment despite multiple documented attempts to address non-participation; D. Member/enrollee refuses treatment; E. Member/enrollee is not making progress toward treatment goals with no reasonable expectation of progress using this treatment approach; F. It is reasonably predicted that continuing improvement can occur after discontinuation of biofeedback with ongoing psychotherapy, medication management and/or community support.N/A

    Any single condition is sufficient for discharge

    Unsupported / Experimental

    Unsupported uses: Current evidence does not support the safety and efficacy of biofeedback for any behavioral health diagnosis other than those noted in this policy as medically necessary; there is insufficient scientific evidence to support the efficacy of neurosound/biosound treatments typically billed under neurofeedback CPT codes.N/A

    These uses are considered unsupported by current evidence

    Biofeedback is not supported by current evidence for behavioral health diagnoses outside the limited indications specified in this policy. In particular, therapies described as neurosound/biosound that are sometimes billed under neurofeedback or other biofeedback CPT codes lack sufficient scientific evidence of efficacy and are considered unsupported for behavioral health indications.

    Coverage of biofeedback services is subject to the terms, conditions, exclusions, and limitations of the member's coverage documents and applicable plan administrative policies. For Medicaid members, state Medicaid coverage provisions take precedence if they conflict with this clinical policy; providers should consult the applicable state Medicaid manual. The Health Plan may change or withdraw this policy and prior authorization or other administrative requirements may apply per the member's contract.

    Current evidence does not support the use of biofeedback for behavioral health diagnoses beyond the anxiety disorders and post-traumatic stress disorder listed as medically necessary in this policy. As noted, there is insufficient scientific evidence to support neurosound/biosound treatments and similar modalities for behavioral health conditions; such uses are considered not medically necessary under this policy.

    Coding

    Referenced CPT codesCPT
    90901Biofeedback training by any modality
    9087530 minutes of individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with patient), with psychotherapy
    9087645 minutes of individual psychophysiological therapy incorporating biofeedback training by any modality (face-to-face with the patient), with psychotherapy

    Provider Actions, Authorization & Documentation Requirements

    Prior Authorization

    Prior Authorization Required

    Prior authorization is required for initial treatment and continuation reviews. Up to 25 initial biofeedback sessions for behavioral health disorders require prior authorization; requests for up to 20 additional continuation sessions will be reviewed case-by-case by a Medical Director. Prior authorization requirements are subject to the member's coverage documents and the Health Plan's administrative policies.

    • Up to 25 initial sessions require prior authorization
    • Continuation up to 20 additional sessions reviewed case-by-case
    Note

    Adjunctive Treatment Requirement

    Biofeedback must be provided as an adjunctive intervention — part of a comprehensive treatment plan that includes other primary evidence-based treatments (for example, psychotherapy and/or medication management). The treatment plan must be individualized with realistic goals, structured to achieve documented expected benefit, and include a documented planned transition out of biofeedback from the start of treatment.

    • Biofeedback is adjunctive to primary evidence-based interventions

    Treatment Modalities — Neurofeedback and Biofeedback

    Neurofeedback / Biofeedback

    Modality description: Neurofeedback involves scalp sensors and real-time feedback to modulate brain electrical activity; biofeedback includes other physiologic signals and is a non-invasive technique used as an adjunctive clinical tool rather than a stand-alone treatment.N/A

    Modality described for clinical context

    Biofeedback / Neurofeedback

    modalities cited: Biofeedback and EEG-based neurofeedback interventions are discussed in the literature for conditions including anxiety disorders, PTSD, OCD, ADHD, and depression; evidence is variable across indications.N/A

    Evidence grouping and literature citations highlighted

    Visit Limits and Quantity Constraints

    Visit limits — behavioral health-related biofeedback
    Initial courseUp to 25 sessions of initial behavioral health-related biofeedback are considered medically necessary when ALL initiation criteria (A–L) are met
    ContinuationUp to an additional 20 sessions may be approved on a case-by-case basis by a Medical Director when continuation criteria (including ≥25% improvement since last review) are met
    Review requirementContinuation requests for additional sessions require Medical Director review and documentation of ongoing criteria and progress
    Progress threshold for continuationAt least 25% reduction in severity compared to the last review is required to support continuation

    Definitions

    Definitions — Biofeedback / Neurofeedback
    Biofeedback (general)A non-invasive technique enabling an individual to learn to change physiological activity to improve health and performance
    Neurofeedback (EEG biofeedback)A type of biofeedback focused on the central nervous system that uses scalp sensors to measure brain electrical activity and provides real-time feedback to help the individual modulate brain function
    Adjunctive useBiofeedback/neurofeedback are intended as adjunctive tools to other standard interventions and not as stand-alone treatments
    Mechanism (neurofeedback)Sensors detect, amplify, and record brain activity which is processed and fed back to the brain (audio, visual, electrical, magnetic, or tactile stimuli) to induce self-regulation
    Evidence summary — Biofeedback / Neurofeedback
    Systematic reviews and meta-analyses cited

    Background

    Neurofeedback is a form of biofeedback that uses scalp sensors to record the brain’s electrical activity (EEG) and provides real-time feedback to the individual to facilitate self-regulation of central nervous system activity. It is delivered as a noninvasive, adjunctive intervention alongside standard evidence‑based treatments rather than as a stand‑alone therapy. Practical implementation varies and standardized regulation and outcome evidence across behavioral health indications remain limited.

    Policy Summary
    PayerAmbetter Nevada
    PolicyBiofeedback for Behavioral Health Disorders
    Policy CodePolicy CP.BH.300
    Change TypeNo material change
    Effective Date
    Next Review Date
    Key ActionObtain prior authorization to request up to 25 initial biofeedback sessions and document diagnosis, validated severity scores, treatment plan and practitioner training for review.
    SourceLink
    On This Page
    Coverage Criteria for Biofeedback / NeurofeedbackCodingProvider Actions, Authorization & Documentation RequirementsTreatment Modalities — Neurofeedback and BiofeedbackVisit Limits and Quantity ConstraintsDefinitionsBackground
  1. Individualized treatment plan with realistic goals and planned transition out of biofeedback
    2. Documentation Required

    Required Documentation

    Providers must document the clinical rationale and measurable outcomes for biofeedback. Required documentation includes: the DSM diagnosis; evidence of functional impairment on a recognized validated standardized severity scale; an individualized treatment plan with stated goals and objectives; evidence that standard outpatient treatments have been insufficient; the member's motivation and ability to participate; practitioner qualifications/certification; and measurable response using symptom‑specific validated scales.

    • Document DSM diagnosis and practitioner qualifications
    • Validated severity scales documenting functional impairment and baseline scores
    • Individualized treatment plan with goals, expected benefit, and planned transition
    • Evidence that standard treatments were insufficient and measurable response on validated scales
    Denial Risk

    Denial Triggers

    Requests may be denied if medical necessity criteria or required documentation are not met. Common denial triggers include absence of a covered DSM diagnosis, lack of documented functional impairment on validated scales, no evidence that standard evidence-based treatments were tried or were insufficient, inadequate documentation of individualized goals and planned transition, or lack of qualified provider certification.

    • No documented DSM diagnosis meeting policy criteria
    • No validated-scale evidence of functional impairment
    • No documentation that standard treatments were tried or insufficient
    • Missing individualized treatment plan, goals, or transition plan
    • Provider lacks documented biofeedback training/certification
    Note

    Claims, Coverage & Administrative Notes

    Coverage determinations and claims submission must follow the member's coverage documents, state Medicaid provisions where applicable, and Health Plan administrative rules. The Health Plan retains discretion to interpret policy language and apply exclusions, limitations, and administrative requirements.

    • Follow member's contract and plan-level claim submission rules
    • State Medicaid provisions override conflicting policy language for Medicaid members
    • Health Plan may change, amend, or withdraw this clinical policy
    Multiple systematic reviews and meta-analyses of biofeedback/neurofeedback for conditions including OCD, ADHD, anxiety, and depression are referenced (e.g., Ferreira et al. 2019; Enriquez-Geppert et al. 2019; Fernández-Alvarez et al. 2022)
    Evidence for anxiety and depressionRecent reviews report mixed but some positive findings for neurofeedback/biofeedback in anxiety and depressive symptoms (e.g., Tolin et al. 2020; Hou et al. 2021; Fernández-Alvarez et al. 2022)
    EEG-based neurofeedback reviewsRecent reviews specifically evaluate EEG-based neurofeedback as a therapeutic intervention for depression and other disorders (e.g., Patil et al. 2023; Patil et al. cited)
    National guidance referencedCenters for Medicare & Medicaid Services National Coverage Determination for Biofeedback Therapy is cited among the references